Campbell & CO Investment Adviser LLC Alnylam Pharmaceuticals, Inc. Transaction History

Campbell & CO Investment Adviser LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$146.51 - $198.2 $1.87 Million - $2.53 Million	-12,757 Reduced 54.58%	10,614 $1.59 Million
Q4 2023 Feb 13, 2024	BUY	$151.41 - $196.57 $3.54 Million - $4.59 Million	23,371 New	23,371 $4.47 Million
Q3 2022 Nov 14, 2022	SELL	$138.54 - $232.0 $413,264 - $692,056	-2,983 Reduced 53.84%	2,558 $512,000
Q2 2022 Aug 09, 2022	BUY	$120.42 - $169.29 $323,809 - $455,220	2,689 Added 94.28%	5,541 $808,000
Q1 2022 May 09, 2022	BUY	$127.18 - $173.91 $362,717 - $495,991	2,852 New	2,852 $466,000
Q4 2021 Feb 10, 2022	SELL	$159.56 - $209.29 $207,428 - $272,077	-1,300 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$169.75 - $207.73 $220,675 - $270,049	1,300 New	1,300 $245,000
Q3 2018 Nov 08, 2018	SELL	$87.52 - $122.67 $236,566 - $331,577	-2,703 Closed	0 $0
Q2 2018 Jul 13, 2018	BUY	$88.31 - $107.8 $238,701 - $291,383	2,703 New	2,703 $266,000

645

109M

1.28M

1.22M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $32.8B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.